X 
Board Meetings
Home | Market Info | Company Profile | Board Meetings
Indrayani Biotech Ltd.
BSE CODE: 526445   |   NSE CODE: NA   |   ISIN CODE : INE007C01021   |   27-Sep-2024 12:38 Hrs IST
BSE NSE
Rs. 40.79
-0.02 ( -0.05% )
 
Prev Close ( Rs.)
40.81
Open ( Rs.)
40.15
 
High ( Rs.)
41.64
Low ( Rs.)
39.20
 
Volume
30517
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
Source DateBoard Meeting DateDetails
08-Aug-2024 14-Aug-2024 Quarterly Results
24-Jul-2024 27-Jul-2024 Inter alia, to consider and approve the following items of business:- 1. To approve the increase and reclassification of authorized share capital of the company subject to the approval of the shareholders. 2. To increase the limit of investment in the total paid up capital of the Company by foreign portfolio investors, foreign institutional investors and non-resident Indians subject to the approval of the shareholders. 3. To consider and approve material related party transactions between the Company and subsidiaries subject to the approval of the shareholders. 4. To consider and approve Directors? report and annexures thereon. 5. To take note of the Secretarial audit report 6. To fix the date, time, venue and mode of 32ndAnnual General Meeting of the Company and approve the draft Notice for convening the said General Meeting. 7. To appoint the Scrutinizer for 32nd Annual General Meeting of the Company. 8. Other business matters.
23-May-2024 30-May-2024 Audited Results
05-Feb-2024 10-Feb-2024 Quarterly Results
08-Jan-2024 10-Jan-2024 Increase in Authorised Capital & Inter alia, to transact the following business: 1. To consider the proposal for increasing the authorized share capital subject to the shareholders? approval. 2. To consider and approve the conversion of unsecured loans into equity under Section 62(3) of the Companies Act, 2013 subject to the shareholders? approval. 3. Any other business with the permission of the Chair.
09-Nov-2023 14-Nov-2023 Quarterly Results
27-Oct-2023 01-Nov-2023 Dividend on Preference Shares & Inter alia, to consider and approve:- 1. To recommend Payment of dividend on 12% Compulsorily Convertible Preference Shares. 2. To consider and approve the allotment of Equity shares by conversion of Compulsorily Convertible Preference Shares subject to lock in period of 6 months. 3. To consider and approve the conversion of Warrants into Equity Shares subject to lock in period of 6 months. 4. Any other matter with the permission of the chair.
07-Aug-2023 11-Aug-2023 Quarterly Results
07-Jun-2023 14-Jun-2023 Audited Results
23-May-2023 30-May-2023 Audited Results
Page 1 of 11
PREV || NEXT